Literature DB >> 18981186

Retinoblastoma protein (pRb), but not p107 or p130, is required for maintenance of enterocyte quiescence and differentiation in small intestine.

Jun Guo1, Shannon Longshore, Rajalakshmi Nair, Brad W Warner.   

Abstract

The function of retinoblastoma protein (pRb) in the regulation of small intestine epithelial cell homeostasis has been challenged by several groups using various promoter-based Cre transgenic mouse lines. Interestingly, different pRb deletion systems yield dramatically disparate small intestinal phenotypes. These findings confound the function of pRb in this dynamic tissue. In this study, Villin-Cre transgenic mice were crossed with Rb (flox/flox) mice to conditionally delete pRb protein in small intestine enterocytes. We discovered a novel hyperplasia phenotype as well as ectopic cell cycle reentry within villus enterocytes in the small intestine. This phenotype was not seen in other pRb family member (p107 or p130) null mice. Using a newly developed crypt/villus isolation method, we uncovered that expression of pRb was undetectable, whereas proliferating cell nuclear antigen, p107, cyclin E, cyclin D3, Cdk2, and Cdc2 were dramatically increased in pRb-deficient villus cells. Cyclin A, cyclin D1, cyclin D2, and Cdk4/6 expression was not affected by absent pRb expression. pRb-deficient villus cells appeared capable of progressing to mitosis but with higher rates of apoptosis. However, the cycling villus enterocytes were not completely differentiated as gauged by significant reduction of intestinal fatty acid-binding protein expression. In summary, pRb, but not p107 or p130, is required for maintaining the postmitotic villus cell in quiescence, governing the expression of cell cycle regulatory proteins, and completing of absorptive enterocyte differentiation in the small intestine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18981186      PMCID: PMC2610504          DOI: 10.1074/jbc.M806133200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Isolation of intestinal epithelial cells for the study of differential gene expression along the crypt-villus axis.

Authors:  P G Traber; D L Gumucio; W Wang
Journal:  Am J Physiol       Date:  1991-06

Review 2.  Wnt signalling in stem cells and cancer.

Authors:  Tannishtha Reya; Hans Clevers
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

Review 3.  Pocket proteins and cell cycle control.

Authors:  David Cobrinik
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

4.  A low-temperature method for the isolation of small-intestinal epithelium along the crypt-villus axis.

Authors:  N Flint; F L Cove; G S Evans
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

5.  Induction of retinoblastoma gene expression during terminal growth arrest of a conditionally immortalized fetal rat lung epithelial cell line and during fetal lung maturation.

Authors:  R A Levine; T Hopman; L Guo; M J Chang; N Johnson
Journal:  Exp Cell Res       Date:  1998-03-15       Impact factor: 3.905

6.  Intestinal epithelial cell surface membrane glycoprotein synthesis. II. Glycosyltransferases and endogenous acceptors of the undifferentiated cell surface membrane.

Authors:  M M Weiser
Journal:  J Biol Chem       Date:  1973-04-10       Impact factor: 5.157

7.  Use of normal and transgenic mice to examine the relationship between terminal differentiation of intestinal epithelial cells and accumulation of their cell cycle regulators.

Authors:  C Chandrasekaran; C M Coopersmith; J I Gordon
Journal:  J Biol Chem       Date:  1996-11-08       Impact factor: 5.157

8.  Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb.

Authors:  W R MacLellan; A Garcia; H Oh; P Frenkel; M C Jordan; K P Roos; M D Schneider
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

9.  A pRb-independent mechanism preserves the postmitotic state in terminally differentiated skeletal muscle cells.

Authors:  Grazia Camarda; Francesca Siepi; Deborah Pajalunga; Camilla Bernardini; Rossella Rossi; Alessandra Montecucco; Ettore Meccia; Marco Crescenzi
Journal:  J Cell Biol       Date:  2004-11-01       Impact factor: 10.539

10.  Expression of SV-40 T antigen in the small intestinal epithelium of transgenic mice results in proliferative changes in the crypt and reentry of villus-associated enterocytes into the cell cycle but has no apparent effect on cellular differentiation programs and does not cause neoplastic transformation.

Authors:  S M Hauft; S H Kim; G H Schmidt; S Pease; S Rees; S Harris; K A Roth; J R Hansbrough; S M Cohn; D J Ahnen
Journal:  J Cell Biol       Date:  1992-05       Impact factor: 10.539

View more
  50 in total

1.  Fasting protects mice from lethal DNA damage by promoting small intestinal epithelial stem cell survival.

Authors:  Kelsey L Tinkum; Kristina M Stemler; Lynn S White; Andrew J Loza; Sabrina Jeter-Jones; Basia M Michalski; Catherine Kuzmicki; Robert Pless; Thaddeus S Stappenbeck; David Piwnica-Worms; Helen Piwnica-Worms
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-07       Impact factor: 11.205

2.  Ribosome biogenesis dysfunction leads to p53-mediated apoptosis and goblet cell differentiation of mouse intestinal stem/progenitor cells.

Authors:  A Stedman; S Beck-Cormier; M Le Bouteiller; A Raveux; S Vandormael-Pournin; S Coqueran; V Lejour; L Jarzebowski; F Toledo; S Robine; M Cohen-Tannoudji
Journal:  Cell Death Differ       Date:  2015-06-12       Impact factor: 15.828

3.  The effect of impaired angiogenesis on intestinal function following massive small bowel resection.

Authors:  Jose Diaz-Miron; Raphael Sun; Pamela Choi; Joshua Sommovilla; Jun Guo; Christopher R Erwin; Junjie Mei; G Scott Worthen; Brad W Warner
Journal:  J Pediatr Surg       Date:  2015-03-14       Impact factor: 2.545

4.  Both epidermal growth factor and insulin-like growth factor receptors are dispensable for structural intestinal adaptation.

Authors:  Raphael C Sun; Jose L Diaz-Miron; Pamela M Choi; Joshua Sommovilla; Jun Guo; Christopher R Erwin; Brad W Warner
Journal:  J Pediatr Surg       Date:  2015-03-14       Impact factor: 2.545

5.  Retinoblastoma family proteins have distinct functions in pulmonary epithelial cells in vivo critical for suppressing cell growth and tumorigenesis.

Authors:  David S Simpson; Nicole A Mason-Richie; Caitlin A Gettler; Kathryn A Wikenheiser-Brokamp
Journal:  Cancer Res       Date:  2009-11-03       Impact factor: 12.701

6.  Deletion of p38-alpha mitogen-activated protein kinase within the intestinal epithelium promotes colon tumorigenesis.

Authors:  Derek Wakeman; John E Schneider; Jingxia Liu; Wambul S Wandu; Christopher R Erwin; Jun Guo; Thaddeus S Stappenbeck; Brad W Warner
Journal:  Surgery       Date:  2012-08       Impact factor: 3.982

7.  p38 MAPK regulates Bax activity and apoptosis in enterocytes at baseline and after intestinal resection.

Authors:  Derek Wakeman; Jun Guo; Jethrina A Santos; Wambui S Wandu; John E Schneider; Mark E McMellen; Jennifer A Leinicke; Christopher R Erwin; Brad W Warner
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-01       Impact factor: 4.052

8.  Epithelial IGF1R is dispensable for IGF2 mediated enhanced intestinal adaptation in retinoblastoma-deficient mice.

Authors:  Raphael C Sun; Pamela M Choi; Jose L Diaz-Miron; Joshua Sommovilla; Jun Guo; Christopher R Erwin; Brad W Warner
Journal:  J Pediatr Surg       Date:  2017-03-18       Impact factor: 2.545

Review 9.  The rb pathway and cancer therapeutics.

Authors:  W Du; J S Searle
Journal:  Curr Drug Targets       Date:  2009-07       Impact factor: 3.465

10.  Viral oncogene expression in the stem/progenitor cell compartment of the mouse intestine induces adenomatous polyps.

Authors:  Maria Teresa Sáenz Robles; Jean Leon Chong; Christopher Koivisto; Anthony Trimboli; Huayang Liu; Gustavo Leone; James M Pipas
Journal:  Mol Cancer Res       Date:  2014-07-03       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.